Cue Biopharma (CUE)
(Delayed Data from NSDQ)
$1.62 USD
-0.01 (-0.31%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.29 | 5.75% |
Earnings Summary
For their last quarter, Cue Biopharma (CUE) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.30 per share. This reflects a positive earnings surprise of 16.67%. Look out for CUE's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.29 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for CUE
Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks
CUE: What are Zacks experts saying now?
Zacks Private Portfolio Services